Related Experiment Video
Updated: May 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular disease in chronic kidney disease: untying the Gordian knot
R Hajhosseiny1, K Khavandi, D J Goldsmith
1MRC Centre for Transplantation and Renal Unit, Guy's & St. Thomas' NHS Foundation Trust, King's College Academic Health Partners, London, UK.
Insights
Chronic kidney disease (CKD) significantly elevates cardiovascular disease (CVD) risk, often preceding end-stage renal disease (ESRD). This review explores the CKD-CVD link and proposes interim management strategies due to limited trial evidence.
Area of Science:
- Nephrology and Cardiology
- Understanding the complex interplay between kidney function and cardiovascular health.
Background:
- Chronic kidney disease (CKD) impacts 10-13% of the global population.
- CKD patients face a substantially higher risk of cardiovascular disease (CVD) compared to the general population.
- CVD progression in CKD patients often occurs before reaching end-stage renal disease (ESRD).
Purpose of the Study:
- To elucidate the pathophysiological mechanisms linking CKD and CVD.
- To review existing interventional strategies for managing CVD in CKD patients.
- To highlight the current scarcity of randomized controlled trial (RCT) evidence in this field.
Main Methods:
- Comprehensive literature review focusing on the relationship between CKD and CVD.
- Analysis of proposed pathophysiological pathways including endothelial dysfunction, dyslipidemia, inflammation, left ventricular hypertrophy, and cardiac autonomic dysfunction.
- Identification of potential interventional strategies and interim measures.
Main Results:
- CKD is a major independent risk factor for CVD.
- Multiple mechanisms contribute to the elevated CVD risk in CKD.
- There is a significant lack of high-quality RCT evidence to guide interventions.
Conclusions:
- The link between CKD and CVD is robust and multifactorial.
- Pragmatic interim measures are necessary while awaiting definitive RCTs.
- Further research, particularly RCTs, is crucial for evidence-based management of CVD in CKD.
Abstract:
Chronic kidney disease (CKD) affects around 10-13% of the general population, with only a small proportion in end stage renal disease (ESRD), either on dialysis or awaiting renal transplantation. It is well documented that CKD patients have an extremely high risk of developing cardiovascular disease (CVD) compared with the general population, so much so that in the early stages of CKD patients are more likely to develop CVD than they are to progress to ESRD. Various pathophysiological pathways and explanations have been advanced and suggested to account for this, including endothelial dysfunction, dyslipidaemia, inflammation, left ventricular hypertrophy and cardiac autonomic dysfunction. In this review, we try to understand and further explore the link between CKD and CVD, as well as offering interventional advice where available, while exposing the current lack of RCT-based research and trial evidence in this area. We also suggest pragmatic Interim measures we could take while we wait for definitive RCTs.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Nephropathy
Heart Failure Drugs: Diuretics
